plasminogen activator

基本解释

Objective To investigate the relationship between the plasminogen activator inhibitor 1(PAI 1) promotor region gene polymorphism and cerebral stroke.
目的探讨纤溶酶原激活物抑制物- 1（ PAI- 1）启动子区基因多态性与脑卒中的关系。
ObjectiveTo study the role and significance of plasminogen activator inhibitor-1(PAI-1) in renal fibrosis(RF) after damage and elucidate the molecular pathogenetic mechanisms of RF.
为探讨纤溶酶原激活物抑制因子1（PAI 1）在肾损伤后纤维化中的作用和意义，揭示其发病的分子病理机制。
Objective To study the expression of plasminogen activator inhibitor-1(PAI-1) of the blood serum and plaques in atherosclerotic rabbits in order to explore the effect of PAI-1 on atherosclerosis (AS).
目的通过对动脉粥样硬化（AS）兔血清和粥样硬化斑块中纤溶酶原激活物抑制物-1（PAI-1）表达的研究，探讨PAI-1在AS中的作用。

Genentech's Activase, also known as tissue plasminogen activator, is approved for use only up to three hours after stroke.
FORBES: Brain Repair
For now, treatment of strokes is pretty much limited to Genentech's clot-busting drug, Activase, a tissue plasminogen activator, which is primarily used to treat heart attacks.
FORBES: Repairing The Brain

纤溶酶原激活剂
Objective: To evaluate the efficacy and safety of recombinant tissue plasminogen activator in hyper acute cerebral infarction.
目的：评价重组组织型纤溶酶原激活剂(rt-PA)治疗急性脑梗死的疗效及安全性。
纤溶酶原激活因子
Objective: To research the effect of urokinase-type plasminogen activator receptor (uPAR) on human sperm viability, motility rate, and sperm acrosome reaction(AR) and investigate the mechanism.
目的:研究尿激酶型纤溶酶原激活因子受体(uPAR)在维持正常人精子活力、活率以及参与精子顶体反应过程中的作用,并探讨其相关机制。
纤维蛋白溶霉原激活剂

纤溶酶原激活剂
In this paper, we used yeast a-factor promoter leader system to express tissue-type plasminogen activator gene efficiently.
参考文献相关文章Download: PDF (1148KB) HTML 0KB Export: BibTeX or EndNote (RIS) Supporting Info 摘要本文首次选用酵母α-因子启动子前导肽系统有效地表达了组织型纤溶酶原激活剂基因。
胞浆素原活化体
纤溶酶原激活物